HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Stephen M Davis Selected Research

Tissue Plasminogen Activator (Alteplase)

8/2015Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke.
8/2015Twenty-Year History of the Evolution of Stroke Thrombolysis With Intravenous Alteplase to Reduce Long-Term Disability.
6/2015Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.
3/2015Endovascular therapy for ischemic stroke with perfusion-imaging selection.
1/2015Selection for delayed intravenous alteplase treatment based on a prognostic score.
4/2014Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.
1/2014Pilot study of intravenous glyburide in patients with a large ischemic stroke.
1/2014A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
10/2013Thrombolysis in the developing world: is there a role for streptokinase?
9/2013Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Stephen M Davis Research Topics

Disease

88Stroke (Strokes)
01/2016 - 04/2002
12Cerebral Hemorrhage
07/2015 - 01/2006
12Hemorrhage
06/2014 - 10/2006
6Infarction
08/2014 - 07/2002
6Hematoma
06/2014 - 01/2006
3Brain Edema (Cerebral Edema)
01/2016 - 08/2013
3Hypertension (High Blood Pressure)
01/2010 - 04/2002
3Intracranial Hemorrhages (Intracranial Hemorrhage)
06/2008 - 02/2006
3Atrial Fibrillation
05/2008 - 04/2002
2Poisoning
12/2015 - 05/2010
2Edema
08/2014 - 01/2014
2Inflammation
04/2014 - 06/2008
2Ischemia
01/2014 - 08/2004
2Human Influenza (Influenza)
01/2012 - 03/2010
2Atherosclerosis
01/2010 - 03/2008
2Hyperglycemia
09/2003 - 07/2002
1Urinary Tract Infections (Urinary Tract Infection)
10/2015
1Dehydration (Water Stress)
10/2015
1Body Weight (Weight, Body)
03/2015
1Neurologic Manifestations (Neurological Manifestations)
11/2014
1Vascular Diseases (Vascular Disease)
04/2014
1Acute Coronary Syndrome
10/2013
1Brain Infarction
06/2013
1Kidney Diseases (Kidney Disease)
06/2013
1Epilepsy (Aura)
11/2012
1Overdose
05/2010
1Brain Ischemia (Cerebral Ischemia)
01/2010
1Cerebral Infarction
05/2008
1Carotid Stenosis (Carotid Artery Stenosis)
05/2008
1Myocardial Ischemia (Ischemic Heart Diseases)
03/2008
1Coma (Comas)
10/2006
1Myocardial Infarction
01/2005
1Diabetes Mellitus
08/2004
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
09/2003

Drug/Important Bio-Agent (IBA)

38Tissue Plasminogen Activator (Alteplase)FDA Link
08/2015 - 04/2003
8Glucose (Dextrose)FDA LinkGeneric
12/2014 - 09/2003
6Factor VIIa (Activated Factor VII)IBA
01/2010 - 01/2006
6recombinant FVIIa (rFVIIa)IBA
01/2010 - 01/2006
5glucuronyl glucosamine glycan sulfate (Vessel)IBA
08/2015 - 08/2002
5Biological Markers (Surrogate Marker)IBA
01/2015 - 04/2004
5Blood Glucose (Blood Sugar)IBA
03/2014 - 07/2002
5disufenton sodium (NXY 059)IBA
06/2008 - 02/2006
4Cytidine Triphosphate (CTP)IBA
11/2013 - 12/2011
4CholesterolIBA
05/2008 - 06/2004
3CreatinineIBA
10/2015 - 03/2007
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2013 - 05/2008
2Opioid Analgesics (Opioids)IBA
12/2015 - 05/2010
2Prescription DrugsIBA
12/2015 - 05/2010
2Glyburide (Glibenclamide)FDA LinkGeneric
08/2014 - 01/2014
24- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
03/2014 - 07/2013
2Warfarin (Coumadin)FDA LinkGeneric
09/2013 - 05/2008
2Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2012 - 07/2011
2TESIBA
01/2010 - 03/2008
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2010 - 05/2008
2Desmodus rotundus salivary plasminogen activator alpha 1IBA
01/2010 - 03/2009
2Heparin (Liquaemin)FDA LinkGeneric
04/2003 - 01/2003
1IceIBA
01/2016
1Vitamin KFDA Link
07/2015
1Proteins (Proteins, Gene)IBA
06/2015
1rivaroxabanIBA
11/2014
1Factor Xa (Coagulation Factor Xa)IBA
11/2014
1Tranexamic Acid (AMCA)FDA Link
06/2014
1Uric Acid (Urate)IBA
05/2014
1C-Reactive ProteinIBA
04/2014
1sulfonylurea receptorIBA
01/2014
1StreptokinaseFDA Link
10/2013
12,6-dinitrotoluene (DNT)IBA
09/2013
1Urea (Carbamide)FDA LinkGeneric
09/2013
1Aligeron (AS 2)IBA
06/2013
1Serine Proteases (Serine Protease)IBA
11/2012
1PlasminogenIBA
07/2012
1AerosolsIBA
01/2012
1Neuroprotective AgentsIBA
07/2011
1SASIBA
05/2010
1BenzodiazepinesIBA
05/2010
1Methadone (Dolophine)FDA LinkGeneric
05/2010
1Hypnotics and Sedatives (Sedatives)IBA
05/2010
1RNA (Ribonucleic Acid)IBA
03/2010
1Angiotensin Receptor AntagonistsIBA
09/2009
1MagnesiumIBA
05/2009
1CalciumIBA
08/2008
1Factor VII (Proconvertin)IBA
01/2006
1Glycosylated Hemoglobin A (Glycosylated Hemoglobin)IBA
08/2004
1SteroidsIBA
01/2004
1nasIBA
08/2003
1Oral ContraceptivesIBA
07/2003
1Estrogens (Estrogen)FDA Link
07/2003
1candesartan cilexetil (Amias)FDA Link
02/2003
1PerindoprilFDA LinkGeneric
02/2003
1candesartanIBA
02/2003

Therapy/Procedure

9Thrombolytic Therapy
10/2014 - 11/2002
3Thrombectomy
10/2015 - 03/2015
2Stents
08/2015 - 03/2015
2Aftercare (After-Treatment)
06/2015 - 07/2013
1Stretchers
09/2013
1Lasers (Laser)
01/2012
1Endarterectomy (Thromboendarterectomy)
05/2008
1Activities of Daily Living (ADL)
12/2006
1Surgical Decompression
09/2003
1Length of Stay
04/2003